A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742585 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Renal Insufficiency
Hyperphosphatemia

Interventions

DRUG: ASP1585
DRUG: placebo

Sponsor

Astellas Pharma Inc